EUVIMEDEUVIMED entdecken
Crossref

Recombinant production of human papillomavirus type 16 E6 and E7 vaccine antigens in Chlamydomonas reinhardtii

Shubham Kumar Dubey, Manu Upadhyay, Vijetna Singh, Bhumi Nath Tripathi

Journal of Biotechnology · 2026-09 · 417 · 265-273

DOI: 10.1016/j.jbiotec.2026.06.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biotechnology, 2026-09. Verfasst von Shubham Kumar Dubey und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh 484887, India. Hauptthemen laut MEDLINE: Chlamydomonas reinhardtii, Oncogene Proteins, Viral, Papillomavirus E7 Proteins, Repressor Proteins. Die Arbeit nennt 46 Literaturangaben. Gefördert von: India Ministry of Science & Technology Department of Biotechnology, India Ministry of Science & Technology Department of Science and Technology, Indian Council of Medical Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cervical cancer remains a major health challenge in low- and middle-income countries, where access to prevention and treatment is limited. Persistent infection with high-risk human papillomavirus (HPV), particularly HPV16, drives malignant transformation through the continuous expression of the viral oncoproteins E6 and E7. These tumor-specific antigens are promising targets for therapeutic vaccine development, but scalable and affordable production systems for recombinant HPV antigens are still lacking. This study establishes Chlamydomonas reinhardtii as a microalgal platform for producing HPV16 E6 and E7 proteins. Codon-optimized sequences encoding HPV16 E6 (519bp) and E7 (481bp) were integrated into the nuclear genome of C. reinhardtii using electroporation-mediated transformation. Protein analysis by SDS-PAGE and immunoblotting detected recombinant E6 (~18kDa) and E7 (~11kDa) at their predicted molecular weights, confirming successful translation. Critically, LC-MS/MS analysis identified multiple high-confidence tryptic peptides corresponding to both HPV antigens, with sequence coverage of 22-35%, providing definitive mass spectrometry-based validation of recombinant protein identity and integrity. These findings show that C. reinhardtii can serve as a scalable, platform for producing clinically relevant HPV16 antigens, supporting its potential application in the development of therapeutic vaccines for HPV-associated cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chlamydomonas reinhardtiiOncogene Proteins, ViralPapillomavirus E7 ProteinsRepressor ProteinsPapillomavirus VaccinesRecombinant ProteinsHuman papillomavirus 16HumansTandem Mass Spectrometry

Stichwörter der Autor:innen

Algal expression systemCervical cancerChlamydomonas reinhardtiiHPV16LC–MS/MSRecombinant protein expressionTherapeutic vaccine

Substanzen

Oncogene Proteins, ViralPapillomavirus E7 Proteinsoncogene protein E7, Human papillomavirus type 16E6 protein, Human papillomavirus type 16Repressor ProteinsPapillomavirus VaccinesRecombinant Proteins

Autor:innen und Institutionen

  • Department of Biotechnology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh 484887, India.
  • Department of Biotechnology, Indira Gandhi National Tribal University, Amarkantak, Madhya Pradesh 484887, India. Electronic address: bhuminath.tripathi@igntu.ac.in.

Förderung

  • India Ministry of Science & Technology Department of Biotechnology
  • India Ministry of Science & Technology Department of Science and Technology
  • Indian Council of Medical Research

Zitieren

APA

Dubey, S. K., Upadhyay, M., Singh, V., & Tripathi, B. N. (2026). Recombinant production of human papillomavirus type 16 E6 and E7 vaccine antigens in Chlamydomonas reinhardtii. Journal of Biotechnology, 417, 265-273. https://doi.org/10.1016/j.jbiotec.2026.06.013

Vancouver

Dubey SK, Upadhyay M, Singh V, Tripathi BN. Recombinant production of human papillomavirus type 16 E6 and E7 vaccine antigens in Chlamydomonas reinhardtii. Journal of Biotechnology. 2026;417:265-273. doi:10.1016/j.jbiotec.2026.06.013

BibTeX
@article{Dubey2026,
  author = {Dubey, Shubham Kumar and Upadhyay, Manu and Singh, Vijetna and Tripathi, Bhumi Nath},
  title = {Recombinant production of human papillomavirus type 16 E6 and E7 vaccine antigens in Chlamydomonas reinhardtii},
  journal = {Journal of Biotechnology},
  year = {2026},
  volume = {417},
  pages = {265--273},
  doi = {10.1016/j.jbiotec.2026.06.013}
}
Kostenlos starten →